Stocks In Play


(MENAFN- Baystreet) MAG Silver Corp.
5/14/2024 10:19 AM EST

  • First Majestic Silver Corp.
    5/14/2024 10:14 AM EST
  • Forsys Metals Corp.
    5/14/2024 10:06 AM EST
  • Fury Gold Mines Limited
    5/14/2024 9:56 AM EST
  • Troilus Gold Corp.
    5/14/2024 9:53 AM EST
  • Galaxy Digital Holdings Ltd.
    5/14/2024 9:48 AM EST
  • Eupraxia Pharmaceuticals Inc.
    5/14/2024 9:45 AM EST
  • Bitfarms Ltd.
    5/14/2024 9:41 AM EST
  • Aya Gold & Silver Inc.
    5/13/2024 12:06 PM EST
  • Medicenna Therapeutics Corp.
    5/13/2024 10:58 AM EST Previous Articles Subscribe to Get Small Cap News & Alerts Glenn Wilkin - Tuesday, May 14, 2024

    Stocks in Play

    5/14/2024 - 10:23 AM EST - KP Tissue Inc. : Reports the Q1 2024 financial and operational results of KPT and Kruger Products Inc. Revenue was $479.4 million in Q1 2024 compared to $451.0 million in Q1 2023, an increase of $28.4 million or 6.3%. Net income was $9.0 million in Q1 2024 compared to a loss of $49.3 million in Q1 2023, an improvement of $58.3 million. KP Tissue Inc.
    shares T are trading down $0.01 at $8.22.





    • About Us
    • Contact Us
    • Advertise
    • License Our Content
    • Jobs
    • Disclaimer
    • Privacy Policy

    Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks

    MENAFN14052024000212011056ID1108212917


  • Baystreet.ca

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.